<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00488007</url>
  </required_header>
  <id_info>
    <org_study_id>2006.414</org_study_id>
    <nct_id>NCT00488007</nct_id>
  </id_info>
  <brief_title>Clinical Trial on Alzheimer Disease, Presbycusis and Hearing Aids</brief_title>
  <official_title>Clinical Trial on Cognitive, Behavioural, Quality of Life and Medico-economic Benefits of Hearing Aids in Alzheimer Disease Patients Suffering From Presbycusis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a 12-months' randomized clinical trial that aims at studying the benefit of bilateral
      hearing aids in hearing impaired patients suffering from a slight to moderate stage Alzheimer
      disease.

      The benefit of this intervention will be studied in the cognitive, behavioural, quality of
      life and economic fields.

      2groups are involved in this trial: Intervention group: 12 months' treatment with active
      hearing aids, fitted hearing impairment Control group: 6 months' treatment with placebo
      hearing aids, followed with 6 months' active hearing aids, fitted hearing impairment
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cognitive benefit evaluated thanks to the ADAS-Cog scale</measure>
    <time_frame>Times of measurements: 0, 6th and 12th month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognitive scales: MMSE, Grober and Buschke, Digit symbol test</measure>
    <time_frame>0, 6th and 12th month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioural scales: IADL, NPI</measure>
    <time_frame>1st week, 3rd 6th 9th and 12th month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life scales: Zarit scale and ADRQL</measure>
    <time_frame>Zarit scale(every 2 months during the study time), ADRQL (0, 6th and 12th month)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consumption questionnaire</measure>
    <time_frame>monthly</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Alzheimer Disease</condition>
  <condition>Presbycusis</condition>
  <arm_group>
    <arm_group_label>Active Hearing aids</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inactive Hearing aids</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Hearing aids turned off</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hearing aids used : PHONAK Savia and Valeo</intervention_name>
    <description>5 hours per day during the first 6 months (active or inactive upon randomization) 5 hours per day during the last 6 months (active)</description>
    <arm_group_label>Active Hearing aids</arm_group_label>
    <arm_group_label>Inactive Hearing aids</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt; 65 year-old

          -  Medical diagnosis of Alzheimer disease

          -  15 ≤ MMSE ≤ 25

          -  No hearing aids in the last 2 years

          -  Motivated caregiver living with the patient

          -  Sensorineural hearing loss

        Exclusion Criteria:

          -  Beginning of an anticholinesterasic treatment in the last 6 months

          -  Change in the anticholinesterasic treatment in the last 2 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc BONNEFOY, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Xavier PERROT</name>
      <address>
        <city>Lyon</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2007</study_first_submitted>
  <study_first_submitted_qc>June 18, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2007</study_first_posted>
  <last_update_submitted>August 29, 2016</last_update_submitted>
  <last_update_submitted_qc>August 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Alzheimer disease</keyword>
  <keyword>Cognitive impairment</keyword>
  <keyword>Sensorineural hearing loss</keyword>
  <keyword>Hearing aids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Presbycusis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

